MPD: Measures involving tail suspension test

Sort/ Pick	Data set	Procedure / Protocol	Treatment	Phenotype Measure / Variable (click to view)	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year
Chesler4:26	Chesler4	tail suspension test	(none)	average frequency climbing, 5 min test [n] TS_frequency_climbing 47026	DO population w/par	9	both	12-16wks	N=8	2013

Chesler4:27	Chesler4	tail suspension test	(none)	average time immobile, 5 min test [s] TS_time_immobile 47027	DO population w/par	9	both	12-16wks	N=8	2013

Chesler4:28	Chesler4	tail suspension test	(none)	average latency to first immobility episode, 5 min test [s] TS_latency_immobile 47028	DO population w/par	9	both	12-16wks	N=8	2013

Gershenfeld1:1	Gershenfeld1	tail suspension test	(none)	TST duration of immobility, effect of saline injection on control group, 6 min test [s] TST_saline 16201 before injection after injection	inbred	12	m	5-10wks	N=5	2003

Gershenfeld1:3	Gershenfeld1	tail suspension test	imipramine	TST duration of immobility, treatment group, 6 min test [s] TST_Rx 16203 baseline imipramine 30mg/kg	inbred	12	m	5-10wks	N=5	2003

Gershenfeld1:5	Gershenfeld1	tail suspension test	imipramine	TST immobility percentage, imipramine vs. saline, 6 min test [%] TST_immobility_pct 16205	inbred	12	m	5-10wks	N=5	2003

JaxCC1:9134	JaxCC1	tail suspension test	(none)	latency to immobility, 5 min test [s] immob_latency_TS 89134	CC	14	both	10-12wks	N=7	2018

JaxCC1:9135	JaxCC1	tail suspension test	(none)	duration of immobility, 5 min test [s] immob_duration_TS 89135	CC	14	both	10-12wks	N=7	2018

JaxKOMP-EAP:235	JaxKOMP-EAP	tail suspension test	(none)	latency to immobility, 5 min test [s] immob_latency_TS latency_to_immobility 100586	KOMP	325	both	11wks	N=10	2015

JaxKOMP-EAP:236	JaxKOMP-EAP	tail suspension test	(none)	duration of immobility, 5 min test [s] immob_duration_TS time_immobile 100587	KOMP	325	both	11wks	N=10	2015

JaxKOMP-EAP:237	JaxKOMP-EAP	tail suspension test	(none)	climbing, 5 min test (yes, no) climbing 100588 categorical	KOMP	343	both	11wks		2015

Pletcher1:1	Pletcher1	tail suspension test	(none)	TST immobility percentage [%] TST 36001	inbred	30	m	7-10wks*	N=16	2007

Project1170:37	Project1170	tail suspension test	fluoxetine	duration mouse was highly mobile, min 1 [s] high_mobile_dur_1 121693 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:39	Project1170	tail suspension test	fluoxetine	duration mouse was highly mobile, min 2 [s] high_mobile_dur_2 121695 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:41	Project1170	tail suspension test	fluoxetine	duration mouse was highly mobile, min 3 [s] high_mobile_dur_3 121697 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:43	Project1170	tail suspension test	fluoxetine	duration mouse was highly mobile, min 4 [s] high_mobile_dur_4 121699 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:45	Project1170	tail suspension test	fluoxetine	duration mouse was highly mobile, min 5 [s] high_mobile_dur_5 121701 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:47	Project1170	tail suspension test	fluoxetine	duration mouse was highly mobile, min 6 [s] high_mobile_dur_6 121703 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:49	Project1170	tail suspension test	fluoxetine	duration mouse was highly mobile, min 7 [s] high_mobile_dur_7 121705 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:51	Project1170	tail suspension test	fluoxetine	duration mouse was highly mobile, total over 7 min [s] high_mobile_dur_tot 121707 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:53	Project1170	tail suspension test	fluoxetine	percentage of time mouse was highly mobile, min 1 [%] high_mobile_pct_1 121709 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:55	Project1170	tail suspension test	fluoxetine	percentage of time mouse was highly mobile, min 2 [%] high_mobile_pct_2 121711 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:57	Project1170	tail suspension test	fluoxetine	percentage of time mouse was highly mobile, min 3 [%] high_mobile_pct_3 121713 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:59	Project1170	tail suspension test	fluoxetine	percentage of time mouse was highly mobile, min 4 [%] high_mobile_pct_4 121715 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:61	Project1170	tail suspension test	fluoxetine	percentage of time mouse was highly mobile, min 5 [%] high_mobile_pct_5 121717 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:63	Project1170	tail suspension test	fluoxetine	percentage of time mouse was highly mobile, min 6 [%] high_mobile_pct_6 121719 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:65	Project1170	tail suspension test	fluoxetine	percentage of time mouse was highly mobile, min 7 [%] high_mobile_pct_7 121721 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:67	Project1170	tail suspension test	fluoxetine	percentage of time mouse was highly mobile, average over 7 min [%] high_mobile_pct_avg 121723 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:69	Project1170	tail suspension test	fluoxetine	duration mouse was mobile, min 1 [s] mobile_dur_1 121725 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:71	Project1170	tail suspension test	fluoxetine	duration mouse was mobile, min 2 [s] mobile_dur2 121727 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:73	Project1170	tail suspension test	fluoxetine	duration mouse was mobile, min 3 [s] mobile_dur_3 121729 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:75	Project1170	tail suspension test	fluoxetine	duration mouse was mobile, min 4 [s] mobile_dur_4 121731 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:77	Project1170	tail suspension test	fluoxetine	duration mouse was mobile, min 5 [s] mobile_dur_5 121733 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:79	Project1170	tail suspension test	fluoxetine	duration mouse was mobile, min 6 [s] mobile_dur_6 121735 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:81	Project1170	tail suspension test	fluoxetine	duration mouse was mobile, min 7 [s] mobile_dur_7 121737 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:83	Project1170	tail suspension test	fluoxetine	duration mouse was mobile, total over 7 min [s] mobile_dur_tot 121739 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:85	Project1170	tail suspension test	fluoxetine	percentage of time mouse was mobile, min 1 [%] mobile_pct_1 121741 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:87	Project1170	tail suspension test	fluoxetine	percentage of time mouse was mobile, min 2 [%] mobile_pct_2 121743 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:89	Project1170	tail suspension test	fluoxetine	percentage of time mouse was mobile, min 3 [%] mobile_pct_3 121745 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:91	Project1170	tail suspension test	fluoxetine	percentage of time mouse was mobile, min 4 [%] mobile_pct_4 121747 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:93	Project1170	tail suspension test	fluoxetine	percentage of time mouse was mobile, min 5 [%] mobile_pct_5 121749 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:95	Project1170	tail suspension test	fluoxetine	percentage of time mouse was mobile, min 6 [%] mobile_pct_6 121751 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:97	Project1170	tail suspension test	fluoxetine	percentage of time mouse was mobile, min 7 [%] mobile_pct_7 121753 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:99	Project1170	tail suspension test	fluoxetine	percentage of time mouse was mobile, average over 7 min [%] mobile_pct_avg 121755 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:101	Project1170	tail suspension test	fluoxetine	duration mouse was immobile, min 1 [s] immobile_dur_1 121757 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:103	Project1170	tail suspension test	fluoxetine	duration mouse was immobile, min 2 [s] immobile_dur_2 121759 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:105	Project1170	tail suspension test	fluoxetine	duration mouse was immobile, min 3 [s] immobile_dur_3 121761 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:107	Project1170	tail suspension test	fluoxetine	duration mouse was immobile, min 4 [s] immobile_dur_4 121763 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:109	Project1170	tail suspension test	fluoxetine	duration mouse was immobile, min 5 [s] immobile_dur_5 121765 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:111	Project1170	tail suspension test	fluoxetine	duration mouse was immobile, min 6 [s] immobile_dur_6 121767 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:113	Project1170	tail suspension test	fluoxetine	duration mouse was immobile, min 7 [s] immobile_dur_7 121769 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:115	Project1170	tail suspension test	fluoxetine	duration mouse was immobile, total over 7 min [s] immobile_dur_tot 121771 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:117	Project1170	tail suspension test	fluoxetine	percentage of time mouse was immobile, min 1 [%] immobile_pct_1 121773 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:119	Project1170	tail suspension test	fluoxetine	percentage of time mouse was immobile, min 2 [%] immobile_pct_2 121775 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:121	Project1170	tail suspension test	fluoxetine	percentage of time mouse was immobile, min 3 [%] immobile_pct_3 121777 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:123	Project1170	tail suspension test	fluoxetine	percentage of time mouse was immobile, min 4 [%] immobile_pct_4 121779 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:125	Project1170	tail suspension test	fluoxetine	percentage of time mouse was immobile, min 5 [%] immobile_pct_5 121781 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:127	Project1170	tail suspension test	fluoxetine	percentage of time mouse was immobile, min 6 [%] immobile_pct_6 121783 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:129	Project1170	tail suspension test	fluoxetine	percentage of time mouse was immobile, min 7 [%] immobile_pct_7 121785 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Project1170:131	Project1170	tail suspension test	fluoxetine	percentage of time mouse was immobile, average over 7 min [%] immobile_pct_avg 121787 group: control fluoxetine	inbred	6	m	10-12wks	N=9	2023

Schalkwyk1:31	Schalkwyk1	tail suspension test	(none)	TST duration of immobility, 5 min test [s] dur_immobil 34531 trial 1 trial 2	inbred	8	m	9-11wks	N=10	2010

Wiltshire2:1	Wiltshire2	tail suspension test	fluoxetine	TST duration of immobility [%] TST 38001 control fluoxetine	inbred	30	m	9-10wks	N=10	2011

Chesler4

tail suspension test

(none)

average frequency climbing, 5 min test [n] TS_frequency_climbing 47026

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

tail suspension test

(none)

average time immobile, 5 min test [s] TS_time_immobile 47027

DO population w/par

9

both

12-16wks

N=8

2013

Chesler4

tail suspension test

(none)

average latency to first immobility episode, 5 min test [s] TS_latency_immobile 47028

DO population w/par

9

both

12-16wks

N=8

2013

Gershenfeld1

tail suspension test

(none)

TST duration of immobility, effect of saline injection on control group, 6 min test [s] TST_saline 16201 before injection after injection

inbred

12

m

5-10wks

N=5

2003

Gershenfeld1

tail suspension test

imipramine

TST duration of immobility, treatment group, 6 min test [s] TST_Rx 16203 baseline imipramine 30mg/kg

inbred

12

m

5-10wks

N=5

2003

Gershenfeld1

tail suspension test

imipramine

TST immobility percentage, imipramine vs. saline, 6 min test [%] TST_immobility_pct 16205

inbred

12

m

5-10wks

N=5

2003

JaxCC1

tail suspension test

(none)

latency to immobility, 5 min test [s] immob_latency_TS 89134

CC

14

both

10-12wks

N=7

2018

JaxCC1

tail suspension test

(none)

duration of immobility, 5 min test [s] immob_duration_TS 89135

CC

14

both

10-12wks

N=7

2018

JaxKOMP-EAP

tail suspension test

(none)

latency to immobility, 5 min test [s] immob_latency_TS latency_to_immobility 100586

KOMP

325

both

11wks

N=10

2015

JaxKOMP-EAP

tail suspension test

(none)

duration of immobility, 5 min test [s] immob_duration_TS time_immobile 100587

KOMP

325

both

11wks

N=10

2015

JaxKOMP-EAP

tail suspension test

(none)

climbing, 5 min test (yes, no) climbing 100588 categorical

KOMP

343

both

11wks

2015

Pletcher1

tail suspension test

(none)

TST immobility percentage [%] TST 36001

inbred

30

m

7-10wks*

N=16

2007

Project1170

tail suspension test

fluoxetine

duration mouse was highly mobile, min 1 [s] high_mobile_dur_1 121693 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

duration mouse was highly mobile, min 2 [s] high_mobile_dur_2 121695 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

duration mouse was highly mobile, min 3 [s] high_mobile_dur_3 121697 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

duration mouse was highly mobile, min 4 [s] high_mobile_dur_4 121699 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

duration mouse was highly mobile, min 5 [s] high_mobile_dur_5 121701 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

duration mouse was highly mobile, min 6 [s] high_mobile_dur_6 121703 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

duration mouse was highly mobile, min 7 [s] high_mobile_dur_7 121705 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

duration mouse was highly mobile, total over 7 min [s] high_mobile_dur_tot 121707 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

percentage of time mouse was highly mobile, min 1 [%] high_mobile_pct_1 121709 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

percentage of time mouse was highly mobile, min 2 [%] high_mobile_pct_2 121711 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

percentage of time mouse was highly mobile, min 3 [%] high_mobile_pct_3 121713 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

percentage of time mouse was highly mobile, min 4 [%] high_mobile_pct_4 121715 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

percentage of time mouse was highly mobile, min 5 [%] high_mobile_pct_5 121717 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

percentage of time mouse was highly mobile, min 6 [%] high_mobile_pct_6 121719 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

percentage of time mouse was highly mobile, min 7 [%] high_mobile_pct_7 121721 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

percentage of time mouse was highly mobile, average over 7 min [%] high_mobile_pct_avg 121723 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

duration mouse was mobile, min 1 [s] mobile_dur_1 121725 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

duration mouse was mobile, min 2 [s] mobile_dur2 121727 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

duration mouse was mobile, min 3 [s] mobile_dur_3 121729 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

duration mouse was mobile, min 4 [s] mobile_dur_4 121731 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

duration mouse was mobile, min 5 [s] mobile_dur_5 121733 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

duration mouse was mobile, min 6 [s] mobile_dur_6 121735 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

duration mouse was mobile, min 7 [s] mobile_dur_7 121737 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

duration mouse was mobile, total over 7 min [s] mobile_dur_tot 121739 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

percentage of time mouse was mobile, min 1 [%] mobile_pct_1 121741 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

percentage of time mouse was mobile, min 2 [%] mobile_pct_2 121743 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

percentage of time mouse was mobile, min 3 [%] mobile_pct_3 121745 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

percentage of time mouse was mobile, min 4 [%] mobile_pct_4 121747 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

percentage of time mouse was mobile, min 5 [%] mobile_pct_5 121749 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

percentage of time mouse was mobile, min 6 [%] mobile_pct_6 121751 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

percentage of time mouse was mobile, min 7 [%] mobile_pct_7 121753 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

percentage of time mouse was mobile, average over 7 min [%] mobile_pct_avg 121755 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

duration mouse was immobile, min 1 [s] immobile_dur_1 121757 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

duration mouse was immobile, min 2 [s] immobile_dur_2 121759 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

duration mouse was immobile, min 3 [s] immobile_dur_3 121761 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

duration mouse was immobile, min 4 [s] immobile_dur_4 121763 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

duration mouse was immobile, min 5 [s] immobile_dur_5 121765 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

duration mouse was immobile, min 6 [s] immobile_dur_6 121767 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

duration mouse was immobile, min 7 [s] immobile_dur_7 121769 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

duration mouse was immobile, total over 7 min [s] immobile_dur_tot 121771 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

percentage of time mouse was immobile, min 1 [%] immobile_pct_1 121773 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

percentage of time mouse was immobile, min 2 [%] immobile_pct_2 121775 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

percentage of time mouse was immobile, min 3 [%] immobile_pct_3 121777 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

percentage of time mouse was immobile, min 4 [%] immobile_pct_4 121779 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

percentage of time mouse was immobile, min 5 [%] immobile_pct_5 121781 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

percentage of time mouse was immobile, min 6 [%] immobile_pct_6 121783 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

percentage of time mouse was immobile, min 7 [%] immobile_pct_7 121785 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Project1170

tail suspension test

fluoxetine

percentage of time mouse was immobile, average over 7 min [%] immobile_pct_avg 121787 group: control fluoxetine

inbred

6

m

10-12wks

N=9

2023

Schalkwyk1

tail suspension test

(none)

TST duration of immobility, 5 min test [s] dur_immobil 34531 trial 1 trial 2

inbred

8

m

9-11wks

N=10

2010

Wiltshire2

tail suspension test

fluoxetine

TST duration of immobility [%] TST 38001 control fluoxetine

inbred

30

m

9-10wks

N=10

2011

Filter Table Results